Distinct spatiotemporal tumor-immune ecologies enable disease prediction in NSCLC patients

被引：0
|
作者：
Prabhakaran, Sandhya
Gatenbee, Chandler
Robertson-Tessi, Mark
Beg, Amer A.
Gray, Jhanelle
Antonia, Scott
Gatenby, Robert A.
Anderson, Alexander R. A.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 10期
关键词：
D O I：
10.1158/1538-7445.EVODYN22-B020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B020
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TUMOR-IMMUNE SIGNATURES ASSOCIATED WITH RESPONSE OR RESISTANCE TO TISLELIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
    Hsu, Chiun
    Edeline, Julien
    Masi, Gianluca
    Ma, Yuk Ting
    Wang, Weilin
    Wege, Henning
    Fei, Cong
    Ling, Chen
    Ma, Xiaopeng
    Zhang, Pei
    Huang, Ruiqi
    Wu, Xikun
    Shen, Zhirong
    Li, Bai
    Duque, Sandra Chica
    Meng, Zhiqiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A387 - A387
  • [42] Utility of the Lung Immune Prognostic Index (LIPI) in prognostication and disease control prediction in advanced NSCLC patients treated with nivolumab.
    Ruiz Banobre, Juan
    Areses Manrique, Maria C.
    Garcia Campelo, Rosario
    Lopez, Rafael
    Afonso Afonso, Francisco J.
    Casal Rubio, Joaquin
    Vazquez Estevez, Sergio
    Azpitarte Raposeiras, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Firvida Perez, Jose Luis
    Mosquera Martinez, Joaquin
    Cortegoso, Alexandra
    Vilchez Simo, Rocio
    Huidobro Vence, Gerardo
    Fernandez Nunez, Natalia
    Quiroga Veiga, Nazaret
    Garcia Mata, Jesus
    Alonso-Jaudenes Curbera, Guillermo
    Anido Herranz, Urbano
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients
    Son, Seung-Myoung
    Woo, Chang Gok
    Kim, Dae Hoon
    Yun, Hyo Yung
    Kim, Hongsik
    Kim, Hee Kyung
    Yang, Yaewon
    Kwon, Jihyun
    Kwon, Minsuk
    Kim, Tae-Yong
    Kim, Hyung-Don
    Koh, June-Young
    Park, Su-Hyung
    Shin, Eui-Cheol
    Han, Hye Sook
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients
    Seung-Myoung Son
    Chang Gok Woo
    Dae Hoon Kim
    Hyo Yung Yun
    Hongsik Kim
    Hee Kyung Kim
    Yaewon Yang
    Jihyun Kwon
    Minsuk Kwon
    Tae-Yong Kim
    Hyung-Don Kim
    June-Young Koh
    Su-Hyung Park
    Eui-Cheol Shin
    Hye Sook Han
    Scientific Reports, 10
  • [45] Prediction of treatment response in alemtuzumab treated RRMS patients by distinct immune phenotypes and deep immune sequencing
    Ruck, T.
    Pfeuffer, S.
    Schulte-Mecklenbeck, A.
    Lindner, M.
    Echterhoff, A.
    Gross, C. C.
    Klotz, L.
    Wiendl, H.
    Meuth, S. G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 650 - 650
  • [46] NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents distinct cancer subtypes
    Schmid, P.
    Kowanetz, M.
    Koeppen, H.
    Zou, W.
    Wistuba, I.
    Kockx, M.
    Kadel, E. E.
    Chaft, J.
    Rizvi, N. A.
    Hirsch, F. R.
    Smith, D.
    Miley, N.
    Leveque, V.
    Shames, D. S.
    Sandler, A.
    Mellman, I.
    Chen, D. S.
    Hegde, P. S.
    Gettinger, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S602 - S602
  • [47] Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations
    Aoki, Kazunori
    Nishito, Yukari
    Motoi, Noriko
    Arai, Yasuhito
    Hiraoka, Nobuyoshi
    Shibata, Tatsuhiro
    Sonobe, Yukiko
    Kayukawa, Yoko
    Hashimoto, Eri
    Takahashi, Mina
    Fujii, Etsuko
    Nishizawa, Takashi
    Fukuda, Hironori
    Ohashi, Kana
    Arai, Kosuke
    Mizoguchi, Yukihiro
    Yoshida, Yukihiro
    Watanabe, Shun-ichi
    Yamashita, Makiko
    Kitano, Shigehisa
    Sakamoto, Hiromi
    Nagata, Yuki
    Mitsumori, Risa
    Ozaki, Kouichi
    Niida, Shumpei
    Kanai, Yae
    Hirayama, Akiyoshi
    Soga, Tomoyoshi
    Maruyama, Toru
    Tsukada, Keisuke
    Yabuki, Nami
    Shimada, Mei
    Kitazawa, Takehisa
    Natori, Osamu
    Sawada, Noriaki
    Kato, Atsuhiko
    Yoshida, Teruhiko
    Yasuda, Kazuki
    Mizuno, Hideaki
    Tsunoda, Hiroyuki
    Ochiai, Atsushi
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (06): : 1026 - 1040
  • [48] Prognostic importance of both stage of the disease and immune infiltrate in the outcome of NSCLC patients
    Dieu-Nosjean, Marie-Caroline
    Goc, Jeremy
    Germain, Claire
    Knockaert, Samantha
    Alifano, Marco
    Lupo, Audrey
    Damotte, Diane
    Validire, Pierre
    Hammond, Scott S. A.
    Fridman, Wolf-Herman
    Sautes-Fridman, Catherine
    CANCER RESEARCH, 2014, 74 (19)
  • [49] Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC
    Sorich, Michael J.
    Rowland, Andrew
    Karapetis, Christos S.
    Hopkins, Ashley M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : E208 - E208
  • [50] Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers
    Li, Anlin
    Chen, Yongjian
    Zhang, Wenda
    Zhong, Haitao
    Ou, Qiyun
    Gu, Yang
    Xia, Junqing
    Lin, Dagui
    Fu, Tuping
    Liu, Ruixin
    Hu, Hai
    Yu, Yunfang
    Yao, Herui
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
12345